Results 241 to 250 of about 136,562 (360)

A Fatal Case of Severe Hemolytic Disease of Newborn Associated with Anti-Jk^b [PDF]

, 2006
Won Duck Kim, Young Hwan Lee
openalex   +1 more source

Confirmation of Fixed Quarterly Riliprubart Regimen in Patients with Cold Agglutinin Disease Using Population PK/PD and Exposure‐Response Analyses

Clinical Pharmacology &Therapeutics, EarlyView.
Riliprubart is a second‐generation, humanized immunoglobulin G4 that inhibits only the activated form of the C1s component of the proximal classical complement pathway. The clinical studies of riliprubart conducted thus far for the treatment of cold agglutinin disease (CAD), a rare autoimmune disease, include a Phase 1 first‐in‐human study in healthy ...
Timothy Chow, Marek Wardecki, Michael Storek, Nancy Wong   +3 more
wiley   +1 more source

Incidence and Risk Factors of Cholestasis in Newborns with Hemolytic Disease-A Case-Control Study. [PDF]

J Clin Med
Drozdowska-Szymczak A, Mazanowska N, Pomianek T, Ludwin A, Krajewski P.   +4 more
europepmc   +1 more source

Use of PopPK and E‐R Analyses toward Explaining Causal Link Between ADAMTS13 in Recombinant vs. Plasma‐Based Therapies and Clinical Effects in cTTP

Clinical Pharmacology &Therapeutics, EarlyView.
Congenital thrombotic thrombocytopenic purpura (cTTP) is an ultra‐rare, potentially life‐threatening condition caused by a deficiency of the blood enzyme ADAMTS13. Until now, ADAMTS13 replacement has been achieved with infusions of plasma or plasma‐based therapies (PBT).
Munjal Patel, Huijuan Xu, Olivier Barriere, Paul Diderichsen, Parth Patwari, Andy Z. X. Zhu, Jean François Marier, Thomas Peyret, Linda T. Wang, Björn Mellgård, Wenping Wang, Indranil Bhattacharya   +11 more
wiley   +1 more source

CAQ Corner: Immune‐mediated complications

, 2022
Liver Transplantation, EarlyView.
Mary Thomson, John R. Lake
wiley   +1 more source

A prehospital protocol for transfusion of low-titer O-positive whole blood in patients with hemorrhagic shock in Los Angeles County: Modeling the risk of hemolytic disease of the fetus and newborn. [PDF]

Transfusion
Wilhelm K, Lauer C, Rangwala R, Zadeh T, Spinella PC, Tolles J.   +5 more
europepmc   +1 more source

A case of hemolytic disease of the newborn due to anti-Kp^a

, 1997
Laura Costamagna, Mario Barbarini, Gianluca Viarengo, Alessia Pagani, D. Isernia, L. Salvaneschi   +5 more
openalex   +1 more source

Annual Banned‐Substance Review 17th Edition—Analytical Approaches in Human Sports Drug Testing 2023/2024

Drug Testing and Analysis, EarlyView.
Scenarios of drug exposure and administration as well as detection assays for drugs and methods of sports doping published between 2023 and 2024 are critically reviewed and evaluated in context with the Prohibited List 2024 as established by the World Anti‐Doping Agency.
Mario  Thevis, Tiia  Kuuranne, Hans  Geyer   +2 more
wiley   +1 more source

Pregnant women's knowledge and clinical management of hemolytic disease of the fetus and newborn in Pará, Brazil. [PDF]

Hematol Transfus Cell Ther
Silva JNGE, de Souza AM, Rosario FMD, Pinto LC.   +3 more
europepmc   +1 more source

Do monocyte ADCC assays accurately predict the severity of hemolytic disease of the newborn caused by antibodies to high-frequency antigens?

, 1996
Stephen F. Garner, A. Devenish
openalex   +1 more source